Corporate InformationMembers

Founder, Representative Director
President and CEO, Chairman of the boardMasamitsu HarataMaster of Agriculture, Master of Business Administration

Experienced all the necessary elements for a start-up under a global environment, such as basic research in academia, clinical development at listed pharmaceutical companies in Japan and overseas, medical affairs, sales marketing and management prior to establishing Human Life CORD Co., Ltd.
Invited Teaching Staff Part-time Lecturer) at the Aging Research Field, Graduate School of Medical Science, Nagoya University

DirectorNobutoshi MatsushitaPh.D. (Agriculture)

Tetsuo Yamanaka

Hiroshi Ishiai

Misao Konishi

Takaaki Nakajima

ManagementMasamitsu HarataMaster of Agriculture, Master of Business Administration

Targeting therapy for intractable leukemia was studied as a researcher of the former Ministry of International Trade and Industry Institute of Industrial Science and Technology, and international results were obtained.
Experienced in the three elements necessary for the drug discovery bio start-up (basic research experience in academia/general administration of clinical development at a pharmaceutical company/management in bioventures) and global business experience.
Founded Human Life CORD Japan Inc. in April 2017, President and Representative Director

Supply Chain ManagementNobutoshi MatsushitaPh.D. (Agriculture)

Experienced pharma professional with a track record of new drug development, launches and life cycle management in specialty care area such as oncology, autoimmune diseases and retinal diseases, as well as leadership experiences at global companies.

R&DMasamichi YamadaMaster of Engineering

Senior professional with extensive experience in drug research and development in the area of rare diseases. Prior to joining our team, he provided leadership and strategic vision at several global pharmaceutical companies. With a strong commitment to bringing cell therapy, a cutting-edge treatment modality, to patients, his team drives R&D and product launch in Human Life CORD.

Reliability AssuranceAkira FutakataPharmacist

Experienced regulatory affairs and quality assurance at various major chemical companies and pharmaceutical companies in Japan before joining our team.
Participated in the establishment of the organization for reliability assurance twice as a result of the company mergers, and experienced the three roles (Supervisor general, QA manager, and safety manager) at each company.
Responsible for regulatory filings and quality assurance for pharmaceutical formulations/active pharmaceutical ingredients, medical devices, and in vitro diagnostics, and has experience in launching new item products.
Provides business and management strategy support to management and is involved in business plan formulation

Management Strategy and Business DevelopmentAkihito NakataPh.D. (Pharmacy), Pharmacist

Joined our team after experience at a foreign consulting firm, and supporting and investing in ventures in the fields of life sciences and healthcare.
In management consulting, he leads new businesses for major Japanese and overseas pharmaceutical and medical device companies, R&D, support for formulation and execution of organizational strategies, and various business reform projects.
In support of ventures, the company provides end-to-end support for Japanese business development activities of over 20 drug discovery ventures from Europe and the U.S.
Executive Director, NPO Corp. IHL/ Healthcare Leadership Study Group

CorporateHiroyasu TogoMaster of Business Administration, Registered Management Consultant

After Experienced business planning, financial accounting at a listed company, he involved in management, business management and IPO preparation at a startup company. The first bio venture he was involved with was listed on the TSE Mothers. Supporting corporate growth by being involved in management improvement, business revitalization, IPO/M&A, etc. of multiple startup companies and small and medium-sized enterprises from an internal and external standpoint.